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Toxicology of Haloacetonitriles
by Johnnie R. Hayes,*' Lyman W. Condie, Jr.,* and Joseph
F. Borzelleca*
Haloacetonitriles are by-products of water chlorination and may form in vivo from the reaction of
residual chlorine with endogenous compounds such as amino acids. Dibromoacetonitrile (DBAN) was
negative in selected mutagenic assays; dichloroacetonitrile (DCAN) was mutagenic in S. typhimurium,
but not in S. cerevisiae. Both DBAN and DCAN may be carcinogenic. There is a paucity of basic toxi-
cological dataforthesecompounds. Thestudiesdescribedwereconductedtodeterminetheacute, subacute,
and subchronic toxicity of DBAN and DCAN. The acute oral LD50 values (mg/kg) in mice and rats are:
DBAN, mice: 289 (M), 303 (F); DBAN, rats: 245 (M), 361 (F); DCAN, mice: 270 (M), 279 (F); DCAN, rats:
339 (M), 330 (F). Death was preceded by slowed respiration, depressed activity, prostration, and coma.
There were no apparent compound-related gross pathological effects.
DBAN (in corn oil) was administered by gavage to male and female CD rats for 14 or 90 days at levels
of 23, 45, 90, and 180 mg/kg/day or 6, 23, and 45 mg/kg/day, respectively. Mortality was 100%o at 180 mg/
kg and 40% (M) and 20% (F) at 90 mg/kg/day. Compound-related mortality was 10% (M) and 5% (F) at 45
mg/kg and 0%o (M) and 10% (F) at 23 mg/kg during the 90-day study. No consistent, significant, adverse
compound-related effects on any of the parameters evaluated were evident. Possible target organs might
be spleen, thymus, and liver. The no-observed adverse-effect level (NOAEL) for 14 days was 45 mg/kg/day
and for 90 days was 23 mg/kg/day.
DCAN (in corn oil) was administered by gavage to male and female CD rats for 14 or 90 days at levels
of 12, 23, 45, and 90 mg/kg/day or 8, 33, and 65 mg/kg/day, respectively. There were no deaths during the
14-day study. Compound-related mortality was 50% (M) and 25% (F) at 65 mg/kg, 10% (M) and 5% (F) at
33 mg/kg, and 5% (M) and 0% (F) at 8 mg/kg during the 90-day study. Body weights were significantly
lower at 90 and 65 mg/kg/day; weight and ratios of spleen and gonads and cholesterol levels were signif-
icantly lower at 90 mg/kg/day. No consistent, significant adverse compound-related effects on any of the
parameters evaluated were evident. The NOAEL for 14 days was 45 mg/kg/day and for 90 days was 8 mg/
kg/day.
Introduction
By-products of water chlorination include trihalo-
methanes (THMs) (1-4) and dihaloacetonitriles
(DHAN) (5-7). For example, dibromoacetonitrile
(DBAN), dichloroacetonitrile (DCAN), and bromo-
chloroacetonitrile (BCAN) were detected in chlorinated
groundwater and surface water supplies of South Flor-
ida but were not found in finished waters with pH 9 or
greater (7). Probable precursors of these DHANs in-
clude amino acids and humic acid (7), algae, and-fulvic
acid (8). It has been reported that DBAN and DCAN
may also be formed in vivo from hypochlorite (9).
Exposure to DHAN may not be limited to consump-
tion ofdrinking water. For example, Trehy and Bieber
(7) cite two proposed uses of DCAN: as an insecticide
for grains (10) and as a biological growth inhibitor in
cooling towers (11).
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Concern about the potential adverse health effects
associated with DHAN was heightened by data from
Simmon et al. (12) showing that DCAN tested positive
in the Salmonella typhimurium TA 100 assay (but did
not increase mitotic recombination in Saccharomyces
cerevisiae). Bull (13) and Meier et al. (14) extended
these findings and reported that DCAN tested positive
in three Salmonella tester strains (TA 98, TA 100, and
TA 1535), but the relatively high cytotoxicity ofDBAN
compromised the in vitro mutagenicity testing (13, 14).
DBAN tested positive, however, in a SENCAR mouse
skin initiation-phorbol promotion model, which gener-
ated inconclusive data on DCAN (13). On the other
hand, Kraybill (15, 16) identified DCAN as a mutagen
or suspected mutagen in drinking water in the United
States.
A review of the literature failed to identify toxicity
data for DHAN. Since data were lacking on these com-
pounds and they were ofinterest to the U.S. Environ-
mental Protection Agency (EPA) because oftheir pres-
ence in drinking water, the following studies were
undertaken as ajoint effort to provide the needed tox-
icological information.HAYES, CONDIE, AND BORZELLECA
Table 1. A series of nitriles.
Acrylonitrile Acetonitrile Dibromoacetonitrile Dichloroacetonitrile
HH ~~~~~~H Br HI IH
Structure C=C-{=N H{-C-GN H-C-=~N H-C--=~N
IlI
H H Br Cl
CAS No. 107-13-1 75-05-8 3252-43-5 3018-12-0
Molecular weight 53.06 41.05 198.86 109.94
Boiling point, °C 77.5-79 81.6 67-69 112-113
Table 2. Acute oral toxicity protocol.
Animals
Adult male and female CD-1 ICR mice; healthy, acclimated,
randomized
Adult male and female CD rats; healthy, acclimated, randomized
Overnight (18 hr) fast (water, no food)
10 males, 10 females per dosage level; five levels
Housing: one animal per plastic shoebox cage with hardwood
sawdust bedding
Feed: Purina Rodent Chow No. 5001; deionized water (in bottles)
Environmental conditions:
Rooms: 22 + 2°C; relative humidity: 40-60%
Light cycle: 12 light/12 dark (7:00 a.m.-7:00 p.m.)
Test material
Identity confirmed by GC-MS
Preparation: day ofadministration
Administration: gavage (stomach tube)
Volume: 10 mL/kg body weight
Specific conditions
Food withheld for 2 hr after dosing
Continuous observations for 1 hour after dosing, hourly for next
4 hr and twice daily for the next 14 days
Cageside observations: include changes in behavior, respiration,
circulation, skin and fur, eyes, mucous membranes; evidence of
tremors or convulsions, lethargy, sleep, coma, salivation, diar-
rhea; time of onset of changes and duration; time of death
All animals that died during the observation period and the sur-
vivors were necropsied
Calculations ofLD50:
Litchfield-Wilcoxon (19)
Table 3. Short-term (14-days) repeated oral dosing protocol.
Animals
Adult male and female CD rats; healthy, acclimated, randomized
10 males, 10 females per group
Housing: One animal per stainless steel suspended cage
Feed: Purina Rodent Chow No. 5001; automatic watering
Environmental conditions:
Rooms: 22 + 2°C; relative humidity: 40-60%
Light cycle: 12 light/12 dark (7:00 a.m.-7:00 p.m.)
Test material
Identity confirmed by GC-MS
Preparation: day of administration
Vehicle: corn oil
Administration: gavage (stomach tube)
Volume: 10 mL/kg body weight
Specific conditions
Groups: controls: naive, vehicle; three dosage levels
Cageside observations: twice daily; behavior, morbidity, mortality;
exceptions noted
Body weights: onset, days 4, 7, 10, 13, and at sacrifice
Hematology: WBC (total, differential); RBC; platelets; hematocrit;
(HCrt)
Serum chemistries: serum glutamic pyruvic transaminase (SGPT),
serum glutamic oxaloacetic transaminase (SGOT), alkaline phos-
phatase (ALP), 5'-nucleotidase, blood urea nitrogen (BUN), bil-
irubin, protein, albumin, globulin, glucose, cholesterol, creati-
nine, phosphorus (P), calcium (C), chlorine (Cl)
Urinalyses: pH, protein, glucose, ketone, blood (Labstix)
Necropsy: gross observations; organ weights
Statistical analysis: appropriate tests including Bartlett's test for
homogeneity, paramnetric ANOVA, Dunnett's multirange test,
Wilcoxon nonparametric test; significance: p
- 0.05
Materials and Methods
Materials and methods are summarized in Tables 1
through 4. The protocols are consistent with those pro-
posed bythe Food and DrugAdministration (FDA) (17)
andthe Organizationfor Economic Cooperation and De-
velopment (OECD) (18).
Sprague-Dawley rats weresupplied by Charles River
Breeding Laboratories (N. Wilmington, MA). DCAN
was obtained from ICN Pharmaceuticals, Inc., K & K
Labs (Plainview, NY) (Lot No. 14128) and had a purity
of98%. Identityandpurity were confirmedby gas chro-
matography-mass spectrometry (GC-MS). DBAN was
obtained from Aldrich Chemical Co. (Milwaukee, WI)
(Lot No. 1201 MJ) and had a purity of 97%. Identity
and purity were confirmed by GC-MS.
Necropsy
The rats were weighed and then anesthetized with
ether; blood wascollectedbycardiacpunctureinto3.0%
sodium citrate (1:10 citrate toblood) forthe hematology
studies and into uncitrated tubes for the serum chem-
istries. Gross pathological examination was performed,
followed by removal and weighing of selected organs.
All tissues were preserved in 10% neutral buffered for-
malin for subsequent histopathological examination.
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Table 4. Subchronic (90-days) oral toxicity protocol.
Animals
Adult male and female CD rats; healthy, acclimated, randomized
20 males, 20 females per group
Housing: One animal per stainless steel suspended cage
Feed: Purina Rodent Chow No. 5001; automatic watering
Environmental conditions:
Rooms: 22 - 2°C; relative humidity: 40-60%
Light cycle: 12 light/12 dark (7:00 a.m.-7:00 p.m.)
Test material:
Identity confirmed by GC-MS
Preparation: day of administration
Vehicle: corn oil
Administration: gavage (stomach tube)
Volume: 10 mL/kg body weight
Specific conditions:
Groups: controls: naive, vehicle; 3 dosage levels
Cageside observations: twice daily; behavior, morbidity, mortality,
exceptions noted
Body weights: onset, once weekly, and at necropsy
Hematology: WBC (total, differential); RBC; platelets; HCrt; Hb;
Serum chemistries: SGPT, SGOT, ALP, 5'-nucleotidase, BUN, bil-
irubin, protein, albumin, globulin, glucose, cholesterol, creati-
nine, P, Ca, Cl
Urinalyses: pH, protein, glucose, ketone, blood (Labstix)
Necropsy: gross observations; organ weights
Statistical analysis: appropriate tests including Bartlett's test for
homogeneity, parametric ANOVA, Dunnett's multirange test,
Wilcoxon nonparametric test; significance: p S 0.05
Abbott Labs (N. Chicago, IL) and Sigma Chemical Co.
(St. Louis, MO). Chloride levels were determined by
using a Buchler chloridometer (Model 4-2500, Buchler
Instruments, Fort Lee, NJ).
Urinalysis
Urinalysis was performed by using Labstix Reagent
Strips from Miles Laboratories, Inc. (Elkhart, IN).
Statistical Evaluation
All datawere subjected to an analysis ofvariance and
test for homogeneity, as well as a Dunnett's t-test, and
nonhomogenous datawere subjected toaWilcoxonrank
sum test. Those values which differed from the vehicle
group at p
- 0.05 were considered significant.
Results
Acute Oral Toxicity of DBAN and DCAN
Acute oral toxicity data are summarized in Table
5.The LD50 values were calculated using the method of
Litchfield and Wilcoxon (19). Ataxia, depressed respi-
ration, depressed activity, and coma preceded death.
No consistent, compound-related, gross pathological ef-
fects were observed at necropsy.
Hematology
ACoulter counter(Model Z81) wasusedto determine
leukocyte, erythrocyte, and platelet numbers. Micro-
hematocrits were determined, and hemoglobin was as-
sayed as cyanomethemoglobin. Leukocyte differentials
were evaluated by the classic Wright's Giemsa staining
procedure. Prothrombin times and plasma fibrinogen
levels were determined using reagents from Dade Di-
agnostics, Inc. (Miami, FL).
Serum Enzyme Chemistry
Serum enzyme levels and calcium and phosphorus
concentrations were determined by using an Abbott Bi-
chromatic Analyzer and diagnostic chemistry kits from
Table 5. Acute oral toxicity of haloacetonitriles in rats and
mice'
Dibromoacetonitrile
Dichloroacetonitrile
Acute oral LD;, mg/kg
Rats Mice
Male Female Male Female
245 361 289 303
(210-286)b (320-410) (253-324) (269-342)
339 330 270 279
(298-387) (300-500) (241-303) (263-296)
Toxicity of DBAN
14-Day Repeated Dosing. The body weight data,
which are summarized in Figures 1 and 2, show that
thedepressioninbodyweightgainwasdose-dependent.
There was 100% mortality at 180 mg/kg/day; all males
were dead by day 4 and all females by day 7. At 90 mg/
kg/day, 40% ofmales and 20% offemales were dead by
day 14.
No significant, consistent, compound-related and
dose-dependent adverse effects were apparent in any
of the hematological or urinary parameters measured,
although a trend toward higher values for hemoglobin,
total red blood count (RBC) and white blood count
(WBC) and fibrinogen was observed in all treated ani-
mals (Tables 6 and 7). Additionally, no consistent, sig-
nificant, compound-related adverse effects were ob-
served in any of the serum chemistry parameters
measured, which are summarized in Tables 6 and 7.
Organ weights and ratios are summarized in Tables 8
and 9. No remarkable findings were observed at nec-
ropsy. Spleen and thymus inmales and liver, lungs, and
thymus in females were affected only at the highest
dose. The significance ofthese effects in the absence of
appropriate biochemical findings is unclear at this time.
90-Day Subchronic Study. The body weight data,
summarized in Figures 3 and 4, show that body weight
gain was significantly depressed only in males at the
highest dose tested (45 mg/kg/day), confirming the ap-
parent greater sensitivity ofthe male rat to the effects aBy gavage; corn oil vehicle.
bMethod ofLitchfieldand Wilcoxon (19); LD50 ± confidence limits.
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FIGURE 1. Mean body weights of male CD rats exposed to dibromoacetonitrile for 14 days.
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FIGURE 2. Mean body weights offemale CD rats exposed to dibromoacetonitrile for 14 days.
of DBAN observed in the acute and 14-day repeated
dosing study. Compound-related mortality was 5% (M)
and 10% (F) at 45 mg/kg and 0% (M) and 10% (F) at 23
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Table 6. Serum chemistry mean values for CD male rats exposed to dibromoacetonitrile for 14 days.'
P.
Si
Si
A
5,
P
A
G
A
GI
Cl
Bi
B'
C:
B'
C
PI
ci
Vehicle D
larameter (corn oil)
,GPT, IU/L 168 ± 55
,GOT, IU/L 339 ± 105 1
LLP, IU/L 360 ± 41 4
'-Nucleotidase, IU/L 18 ± 3
'rotein, g/dL 6.3 ± 0.1 6
dbumin, g/dL 4.0 ± 0.1 4
rlobulin, g/dL 2.3 ± 0.1 2
lb/globulin ratio 1.8 ± 0.1 I
rlucose, mg/dL 265 ± 47 2
'holesterol, mg/dL 66 ± 2
ilirubin, mg/dL 0.3 ± 0.0 C
'UN, mg/dL 15 ± 1
'reatinine, mg/dL 1.3 ± 0.2
,UN/creatinine ratio 13 ± 2
'alcium mg/dL 11.3 ± 0.4 12
'hosphorus, mg/dL 12.0 ± 0.4 ll
hloride, mEq/L 99 ± 2
'All data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
bNo survivors.
Table 7. Serum chemistry mean values for CD female rats exposed to dibromoacetonitrile for 14 days.a
Parameter
SGPT, IU/L
SGOT, IU/L
ALP, IU/L
5'-Nucleotidase, IU/L
Protein, g/dL
Albumin, g/dL
Globulin, g/dL
Alb/globulin ratio
Glucose, mg/dL
Cholesterol, mg/dL
Bilirubin, mg/dL
BUN, mg/dL
Creatinine, mg/dL
BUN/creatinine ratio
Calcium, mg/dL
Phosphorus, mg/dL
Chloride, mEq/L
Vehicle
(corn oil)
74 + 6
178 + 32
236 ± 26
25 ± 4
6.7 ± 0.1
4.3 ± 0.2
2.5 ± 0.1
1.7 ± 0.1
212 ± 17
66 ± 4
0.3 ± 0.0
15 ± 2
1.2 ± 0.1
12 ± 2
11.9 ± 0.4
11.6 ± 0.1
98 ± 1.4
'All data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
bNo survivors.
DBAN dose
23 mg/kg
62 ± 8
138 ± 9
299 ± 29
22 ± 2
6.2 ± 0.3
4.0 ± 0.1
2.2 ± 0.2
1.8 ± 0.1
171 ± 18
58 ± 6
0.2 ± 0.0
13 ± 2
1.0 ± 0.1
15 ± 4
11.1 ± 0.3
10.1 ± 0.6
102 ± 0.7
15, although there are suggestions that the liver could
be affected. Organ weights and ratios are summarized
in Tables 16 and 17. No remarkable findings were ap-
parent at necropsy. Possible target organs were deter-
minedandincludedthethymus, liver, andkidneys. Sup-
porting biochemical evidence for these target organs
was, however, not detectable. The apparent no-ob-
served adverse-effect level (NOAEL) forDBAN, based
on these 90-day data, was determined to be 23 mg/kg/
day.
DBAN dose
180 mg/kg
_b
)BAN dose
23 mg/g
75 ± 9
142 ± 14
166 + 33
17 ± 1
6.5 ± 0.1
4.0 ± 0.0
2.5 ± 0.1
1.6 ± 0.1
:12 ± 41
64 ± 2
0.4 ± 0.0
13 ± 1
0.8 ± 0.1
16 ± 2
2.5 ± 0.6
1.2 ± 0.4
99 ± 2
DBAN dose
45 mg/kg
76 ± 11
172 ± 26
247 ± 29
13 ± 2
6.2 ± 0.1
4.0 ± 0.1
2.2 ± 0.1
1.8 ± 0.1
217 ± 40
74 ± 4
0.2 ± 0.0
10 ± 1
0.9 ± 0.1
12 ± 1*
11.8 ± 0.4
11.3 ± 0.5
99 ± 1
DBAN dose
90 mg/kg
77 ± 19
273 ± 81
187 ± 8*
14 ± 1
4.7 ± 0.4*
2.9 ± 0.3*
1.8 ± 0.1*
1.6 ± 0.2
130 ± 1
95 ± 5*
0.3 ± 0.1
18 ± 6
0.7 ± 0.0*
24 ± 8
9.6 ± 0.6
7.6 ± 0.7*
100 ± 2
DBAN dose
180 mg/kg
b
DBAN dose
45 mg/kg
74 ± 14
182 ± 21
260 ± 24
28 ± 2
6.2 ± 0.1
4.2 ± 0.1
2.1 ± 0.1
2.1 ± 0.1
197 ± 22
66 ± 6
0.3 ± 0.0
13 ± 1
1.0 ± 0.1
14 ± 2
12.1 ± 0.5
10.8 ± 0.5
100 ± 1.2
DBAN dose
90 mg/kg
68 + 11
161 ± 15
179 ± 34
18 ± 4
5.3 ± 0.2*
3.5 ± 0.1*
1.8 ± 0.1*
2.0 ± 0.1
138 ± 17
71 ± 3
0.2 ± 0.0
15 ± 2
0.8 ± 0.0*
19 ± 3
11.1 ± 0.3
9.3 ± 0.7*
101 ± 0.7
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Table 8. Organ weights and ratios of male CD rats exposed to dibromoacetonitrile by gavage for 14 days.'
Vehicle DBAN dose DBAN dose DBAN dose DBAN dose
Organ (corn oil) 23 mg/kg 45 mg/kg 90 mg/kg 180 mg/kg
Body weight, g 275.5 ± 3.2 274.6 ± 5.5 243.7 ± 4.6* 209.4 + 10.1*
Brain, mg 1810 ± 50 1770 ± 60 1760 ± 30 1660 50
% body weight 0.66 ± 0.02 0.65 ± 0.03 0.73 ± 0.02* 0.80 ± 0.06*
Liver, mg 12910 ± 340 11600 ± 1240 11470 ± 1200 10180 + 1890
% body weight 4.69 ± 0.15 4.25 ± 0.45 4.71 ± 0.49 4.72 ± 0.83
% brain weight 719 ± 24 668 ± 72 659 ± 73 630 ± 123
Spleen, mg 640 ± 30 590 ± 50 560 ± 50 420 + 50*
% body weight 0.23 ± 0.01 0.21 ± 0.02 0.23 ± 0.02 0.20 ± 0.02
% brain weight 35.8 ± 1.7 33.2 ± 2.6 31.8 ± 2.8 25.5 ± 3.4*
Lungs, mg 1690 ± 100 1490 ± 90 1440 ± 70 1300 ± 140*
% body weight 0.61 ± 0.03 0.54 ± 0.04 0.59 ± 0.03 0.62 ± 0.06
% brain weight 94.0 ± 6.0 84.6 ± 5.0 81.4 ± 4.1 80.2 ± 11.3
Thymus, mg 510 ± 30 520 ± 40 460 ± 20 240 ± 60*
% body weight 0.19 ± 0.01 0.19 ± 0.01 0.19 ± 0.01 0.11 ± 0.03*
% brain weight 28.7 ± 1.9 29.7 ± 2.7 26.1 ± 1.8 15.2 ± 4.3*
Kidneys, mg 2500 ± 100 2390 ± 90 2080 ± 60* 2130 ± 150*
% body weight 0.91 ± 0.05 0.87 ± 0.03 0.85 ± 0.02 1.02 ± 0.06
% brain weight 139.6 ± 6.9 135.5 ± 3.6 118.1 ± 4.1*b 130.2 ± 12.1
Testes, mg 2700 ± 90 2710 ± 70 2670 ± 60 2690 ± 60
% body weight 0.99 ± 0.04 0.99 ± 0.03 1.10 ± 0.03 1.30 ± 0.07*
% brain weight 150.5 ± 5.5 154.9 ± 6.0 152.0 ± 5.5 163.0 ± 5.2
'All data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
bNo survivors.
Table 9. Organ weights and ratios of female CD rats exposed to dibromoacetonitrile by gavage for 14 days.a
Vehicle DBAN dose DBAN dose DBAN dose DBAN dose
Organ (corn oil) 23 mg/kg 45 mg/kg 90 mg/kg 180 mg/kg
Body weight, g 176.5 ± 6.8 184.9 ± 2.4 181.1 ± 2.8 165.9 ± 5.4 b
Brain, mg 1670 ± 40 1680 ± 40 1640 ± 40 1690 ± 60
% body weight 0.96 ± 0.04 0.91 ± 0.03 0.91 ± 0.03 1.03 ± 0.04
Liver, mg 8590 ± 260 9650 ± 250* 9730 ± 200* 10500 ± 440*
% body weight 4.89 ± 0.12 5.22 ± 0.11 5.39 ± 0.15 6.34 ± 0.24*
% brain weight 515 ± 20 577 ± 24 598 ± 18* 622 ± 23*
Spleen, mg 480 ± 30 450 ± 20 520 ± 30 420 ± 40
% body weight 0.27 ± 0.01 0.24 ± 0.01 0.29 ± 0.02 0.26 ± 0.02
% brain weight 28.6 ± 1.7 27.0 ± 1.0 31.6 ± 1.5 25.0 ± 2.3
Lungs, mg 1580 ± 190 1420 ± 90 1250 ± 60 1090 ± 60*
% body weight 0.88 ± 0.08 0.77 ± 0.05 0.69 ± 0.04 0.66 ± 0.04*
% brain weight 94.1 ± 10.7 84.4 ± 5.9 76.3 ± 2.9 65.0 ± 5.0*
Thymus, mg 400 ± 30 440 ± 30 400 ± 10 210 ± 20*
% body weight 0.23 ± 0.02 0.24 ± 0.02 0.22 ± 0.01 0.13 ± 0.01*
% brain weight 24.4 ± 2.3 26.3 ± 1.6 24.4 ± 1.0 12.9 ± 1.0*
Kidneys, mg 1560 ± 60 1640 ± 40 1620 ± 40 1530 ± 50
% body weight 0.89 ± 0.02 0.89 ± 0.02 0.89 ± 0.03 0.92 ± 0.03
% brain weight 94.0 ± 4.8 97.8 ± 3.2 99.5 ± 3.9 90.9 ± 4.2
Ovaries, mg 110 ± 10 140 ± 10 140 ± 10 120 ± 20
% body weight 0.06 ± 0.00 0.07 ± 0.01 0.08 ± 0.01 0.07 ± 0.01
% brain weight 6.7 ± 0.5 8.2 ± 0.7 8.5 ± 1.0 6.9 ± 0.8
'All data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
bNo survivors.
Toxicity of DCAN
14-Day Repeated Dosing. The body weight data,
summarized in Figures 5 and 6, show that the depres-
sion in body weight gain was dose-dependent. There
was no mortality, and no consistent, significant, com-
pound-related and dose-dependent adverse effects were
observed in any ofthe hematological or urinary param-
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FIGURE 3. Mean body weights ofmale CD rats exposed to dichloroacetonitrile for 14 days.
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FIGURE 4. Mean body weights offemale CD rats exposed to dichloracetonitrile for 14 days.
eters measured, although atrend toward elevated RBC
and WBC was noted in all treated animals. The serum
chemistry values, summarized in Tables 18 and 19, re-
vealed no consistent, significant, compound-related and
dose-dependent adverse effects. Organ weights and ra-
tios are summarized inTables20 and 21. Noremarkable
findings were observed at necropsy, although most or-
gan weights and ratios were significantly lower at the
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Table 10. Serum chemistry mean values for CD male rats exposed to dibromoacetonitrile at day 30 and 31 of subchronic study.a
Parameter Naive
SGPT, IU/L 80 ± 3
SGOT, IU/L 208 ± 16
ALP, IU/L 293 ± 20
5'-Nucleotidase, IU/L 16 ± 3
Protein, g/dL 7.4 ± 0.1
Albumin, g/dL 4.8 ± 0.1
Globulin, g/dL 2.6 ± 0.2
Alb/globulin ratio 2.0 ± 0.2
Glucose, mg/dL 137 ± 8
Cholesterol, mg/dL 78 ± 3
Bilirubin, mg/dL 0.4 ± 0.0
BUN, mg/dL 20 ± 1*
Creatinine, mg/dL 1.2 ± 0.1
BUN/creatinine ratio 17 ± 1*
Calcium, mg/dL 11.8 ± 0.3
Phosphorus, mg/dL 8.6 ± 0.3
Chloride, mEq/L 101 ± 1
aR data expressed as mean ± SEM.
bSigriificantly different from vehicle control (p S 0.05).
Vehicle
(corn oil)
65 ± 3
242 ± 23
319 ± 22
20 ± 5
7.8 ± 0.2
5.1 ± 0.1
2.6 ± 0.2
2.0 ± 0.2
131 ± 7
81 ± 4
0.6 ± 0.1
16 ± 1
1.6 ± 0.1
10 ± 0.6
L2.0 ± 0.6
9.2 ± 0.6
103 ± 1
Table 11. Serum chemistry mean values for CD male rats exposed to dibromoacetonitrile at day 59 and 60 of subchronic study.a
Parameter Naive
SGPT, IU/L 45 4
SGOT, IU/L 204 32
ALP, IU/L 174 24
5'-Nucleotidase, IU/L 14 1
Protein, g/dL 6.8 ± 0.2
Albumin, g/dL 5.0 ± 0.1
Globulin, g/dL 1.8 ± 0.1
Alb/globulin ratio 2.8 ± 0.6
Glucose, mg/dL 148 5
Cholesterol mg/dL 65 4
Bilirubin, mg/dL 0.3 0.0*
BUN, mg/dL 21 1*
Creatinine, mg/dL 1.1 t 0.0
BUN/creatinine ratio 20 1
Calcium, mg/dL 11.0 0.2
Phosphorus, mg/dL 7.1 0.2
Chloride, mEq/L 101 1
"AR data expressed as mean SEM.
Vehicle
(corn oil)
50 ± 2
229 ± 32
220 ± 16
16 ± 1
7.1 ± 0.3
5.2 ± 0.1
1.9 ± 0.2
3.2 ± 1.3
164 ± 8
81 ± 7
0.8 ± 0.4
18 ± 1
1.1 ± 0.2
27 ± 1
11.9 ± 0.4
7.7 ± 0.3
101 ± 1
*Significantly different from vehicle control (p
- 0.05).
highest dose tested (90 mg/kg/day). The significance of
these findings is unclear.
90-Day Subchronic Study. The body weight data,
summarized in Figures 7 and 8, show that body weight
gain wassignificantly depressed in male and female rats
at 65 mg/kg/day. Thefollowingmortality was observed:
at 65 mg/kg, 50% ofmales and 25% offemales had died
by the completion of the study; at 33 mg/kg, 10% of
males and 5% offemales had died; and at 8 mg/kg, 5%
ofmaleshad died. No consistent, compound-related and
DBAN dose
6 mg/kg
51 ± 2
194 ± 17
281 ± 26
16 ± 4
8.1 ± 0.2
5.7 ± 0.1
2.5 ± 0.2
2.1 ± 0.3
144 ± 8
77 ± 7
0.7 ± 0.1
17 ± 1
1.4 ± 0.1
13 ± 1
12.5 ± 0.4
8.7 ± 0.3
101 ± 1
DBAN dose
23 mg/kg
54 ± 3
227 ± 14
310 ± 30
19 ± 5
8.1 ± 0.1
5.6 ± 0.1
2.6 ± 0.3
2.4 ± 0.3
139 ± 12
79 ± 6
0.9 ± 0.1
16 ± 1
1.2 ± 0.1
15 ± 2*
12.6 ± 0.4
9.3 ± 0.3
100 ± 1
DBAN dose
45 mg/kg
70 + 13
222 + 41
287 ± 26
16 ± 4
8.0 ± 0.2
5.2 ± 0.1
2.8 ± 0.2
2.0 ± 0.2
161 ± 10
71 ± 0.1
0.7 ± 0.1
14 ± 1
1.3 ± 0.1
11 ± 0.7
11.8 ± 0.6
9.3 ± 0.5
101 ± 1
DBAN dose
6 mg/kg
55 + 6.5
221 ± 32
192 ± 24
14 ± 1
7.3 ± 0.2
5.4 ± 0.2
1.8 ± 0.3
3.3 ± 2.1
148 ± 5
77 ± 7
0.7 ± 0.2
16 ± 1
1.4 ± 0.1
12 ± 1
12.3 ± 0.3
7.9 ± 0.5
101 ± 1
DBAN dose
23 mg/kg
43 ± 2.7
195 ± 23
226 ± 25
15 ± 1
7.7 ± 0.2
5.7 ± 0.1
2.0 ± 0.2
2.9 ± 1.3
148 ± 7
72 ± 4
0.7 ± 0.1
19 ± 1
1.2 ± 0.1
17 ± 1
12.5 ± 0.3
8.3 ± 0.4
101 ± 1
DBAN dose
45 mg/kg
56 t 8.4
202 t 23
177± 19
14 + 1
7.1 + 0.2
5.4 ± 0.2
1.7 ± 0.3
3.5 ± 2.1
154 + 7
72 + 5
0.8 ± 0.1
16 + 1
0.8 + 0.2
25 + 4
11.7 + 0.4
9.0 + 0.3
101 ± 1
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Table 12. Serum chemistry mean values for CD male rats exposed to dibromoacetonitrile at termination of subchronic study.a
Parameter Naive
SGPT, IU/L 58 ± 14
SGOT, IU/L 200 ± 31 1
ALP, IU/L 159 ± 16 1
5'-Nucleotidase, IU/L 14 ± 1
Protein, g/dL 6.7 ± 0.1*
Albumin, g/dL 5.5 ± 0.1
Globulin, g/dL 1.2 ± 0.1*
Alb/globulin ratio 4.6 ± 0.2
Glucose, mg/dL 138 ± 9 1
Cholesterol, mg/dL 74 ± 5
Bilirubin, mg/dL 0.3 ± 0.0*
BUN, mg/dL 22 ± 1*
Creatinine, mg/dL 1.1 ± 0.0 I
BUN/creatinine ratio 21 ± 1
Calcium, mg/dL 10.4 ± 0.1 1:
Phosphorus, mg/dL 6.0 ± 0.1
Chloride, mEq/L 100 ± 1 1
'All data expressed as mean ± SEM.
*Significantly different from vehicle control (p s 0.05).
Vehicle
(corn oil)
44 ± 4
176 ± 12
191 ± 16
15 ± 1
8.2 ± 0.4
5.2 ± 0.1
2.9 ± 0.5
2.5 ± 0.6
148 ± 7
73 ± 5
0.6 ± 0.1
17 ± 1
1.0 ± 0.1
17 ± 1
1.3 ± 0.5
6.4 ± 0.4
102 ± 1
Table 13. Serum chemistry mean values for CD female rats exposed to dibromoacetonitrile at day 30 and 31 of subchronic study.
Parameter
SGPT, IU/L
SGOT, IU/L
ALP, IU/L
5'-Nucleotidase, IU/L
Protein, g/dL
Albumin, g/dL
Globulin, g/dL
Alb/globulin ratio
Glucose, mg/dL
Cholesterol, mg/dL
Bilirubin, mg/dL
BUN, mg/dL
Creatinine, mg/dL
BUN/creatinine ratio
Calcium mg/dL
Phosphorus, mg/dL
Chloride, mEq/L
Naive
83 + 6*
194 ± 13
184 ± 14
27 ± 3
7.8 ± 0.1
5.3 ± 0.1
2.5 ± 0.2
2.2 ± 0.2
133 ± 5
102 ± 4
0.5 ± 0.0
19 ± 1*
1.3 ± 0.1
15 1
11.7 ± 0.2
7.3 ± 0.3
101 ± 0.7
'All data expressed as mean + SEM.
*Significantly different from vehicle control (p S 0.05).
Vehicle
(corn oil)
49 ± 3
199 ± 13
186 ± 15
27 ± 2
7.6 ± 0.2
5.6 ± 0.2
2.1 ± 0.3
3.4 ± 0.7
124 ± 4
88 ± 3
0.5 ± 0.0
14 ± 1
1.3 ± 0.1
11 ± 1
11.2 ± 0.2
8.0 ± 0.2
100 ± 0.8
dose-dependent adverse effects were observed in any
ofthe hematological and urinary parameters measured.
The serum chemistry values, summarized in Tables 22-
27, revealed few significant, consistent, compound-re-
lated and dose-dependent adverse effects. Theseeffects
included a lowering of cholesterol at the highest dose
tested (65 mg/kg/day) and elevated levels of serum glu-
tamic-pyruvictransaminase (SGPT)suggestingpossible
liver involvement. The significance of decreases in the
activity of selected enzymes is unclear.
DBAN dose
6 mg/kg
69 ± 3
245 ± 52
171 ± 28
17 ± 2
8.2 ± 0.3
5.3 ± 0.2
2.9 ± 0.4
2.3 ± 0.3
139 ± 7
70 ± 5
0.9 ± 0.1
15 ± 1
0.9 ± 0.1
17 ± 2
11.7 ± 0.2
6.9 ± 0.4
101 ± 1
DBAN dose
23 mg/kg
42 ± 4
190 ± 30
192 ± 23
16 ± 1
8.1 ± 0.2
5.8 ± 0.1*
2.3 ± 0.2
2.8 ± 0.4
143 ± 8
69 ± 4
0.8 ± 0.1
17 + 1
1.3 ± 0.0
14 + 0
12.8 + 0.2*
6.7 ± 0.2
102 ± 1
DBAN dose
45 mg/kg
44 ± 5
181 ± 13
157 + 16
13 ± 1
7.0 ± 0.2*
5.8 ± 0.1*
1.2 ± 0.1*
5.8 ± 0.8
134 ± 5
77 ± 5
0.7 ± 0.0
18 ± 1
1.0 ± 0.0
19 ± 1
10.9 ± 0.2
6.5 ± 0.2
102 ± 1
DBAN dose
6 mg/kg
52 ± 3
201 ± 25
195 ± 12
29 + 2
7.9 ± 0.1
5.9 ± 0.1
2.0 ± 0.2
3.1 ± 0.3
136 ± 7
82 ± 4
0.6 ± 0.0
14 ± 1
1.2 ± 0.1
12 ± 1
11.1 ± 0.2
7.2 ± 0.2
101 ± 0.9
DBAN dose
23 mg/kg
41 ± 2
129 ± 10*
208 ± 25
35 ± 5
7.8 ± 0.2
5.9 ± 0.1
1.8 ± 0.3
4.8 ± 2.1
154 ± 5*
89 ± 6
0.6 ± 0.1
13 ± 1
1.0 ± 0.1
15 ± 2
12.0 ± 0.2
8.2 ± 0.4
102 ± 0.7
DBAN dose
45 mg/kg
37 ± 2
152 ± 17
198 + 22
28 ± 3
7.7 ± 0.2
6.1 ± 0.1*
1.6 ± 0.1
3.4 ± 0.4
178 ± 7*
65 ± 3*
0.5 ± 0.1
16 ± 1
1.5 ± 0.2
12 ± 2
12.0 + 0.4
8.6 ± 0.7
100 ± 0.8
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Table 14. Serum chemistry mean values for CD female rats exposed to dibromoacetonitrile at day 59 and 60 of subchronic study.'
Vehicle
Parameter Naive (corn oil)
SGPT, IU/L 47 ± 3 44 ± 3
SGOT, IU/L 203 ± 21 238 ± 34
ALP, IU/L 135 ± 18 150 ± 9
5'-Nucleotidase, IU/L 28 ± 2 23 ± 2
Protein, g/dL 7.3 ± 0.1 7.3 ± 0.2
Albumin, g/dL 5.4 ± 0.1 5.8 ± 0.2
Globulin, g/dL 1.9 ± 0.1 1.5 ± 0.2
Alb/globulin ratio 2.9 ± 0.2 5.6 ± 1.7
Glucose, mg/dL 169 ± 11 154 ± 7
Cholesterol, mg/dL 83 ± 2 88 ± 5
Bilirubin, mg/dL 0.2 ± 0.0* 0.5 ± 0.1
BUN, mg/dL 20 ± 1* 15 ± 1
Creatinine, mg/dL 1.2 ± 0.1 1.4 ± 0.1
BUN/creatinine ratio 18 ± 2* 11 ± 1
Calcium, mg/dL 10.9 ± 0.2 11.4 ± 0.2
Phosphorus, mg/dL 6.2 ± 0.3 6.3 ± 0.3
Chloride, mEq/L 102 ± 1 103 ± 1
aAll data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
DBAN dose
6 mg/kg
40 ± 5
201 ± 35
162 ± 10
25 ± 2
7.3 ± 0.2
6.1 ± 0.1
1.2 ± 0.2
6.1 ± 1.4
161 ± 10
83 ± 4
0.4 ± 0.1
15 ± 1
1.3 ± 0.1
11 ± 0
11.4 ± 0.1
6.0 ± 0.4
115 ± 12
DBAN dose
23 mg/kg
40 ± 4
161 ± 18
189 ± 23
28 ± 2
7.0 ± 0.1
6.2 ± 0.1
0.8 ± 0.1*
9.4 ± 3.7
161 ± 12
83 ± 5
0.3 ± 0.1
16 ± 1
1.0 ± 0.1
17 ± 2*
11.8 ± 0.1
6.4 ± 0.3
101 ± 1
DBAN dose
45 mg/kg
35 + 2
241 ± 43
203 ± 24
26 ± 2
6.9 ± 0.2
6.0 ± 0.1
0.9 ± 0.1
6.4 ± 0.6
168 ± 7
63 ± 4*
0.4 ± 0.1
13 ± 1
0.8 ± 0.1*
18 ± 2*
11.3 ± 0.2
6.9 ± 0.3
101 ± 1
Table 15. Serum chemistry mean values for CD female rats exposed to dibromoacetonitrile at termination of subchronic study.a
Parameter
SGPT, IU/L
SGOT, IU/L
ALP, IU/L
5'-Nucleotidase, IU/L
Protein, g/dL
Albumin, g/dL
Globulin, g/dL
Alb/globulin ratio
Glucose, mg/dL
Cholesterol, mg/dL
Bilirubin, mg/dL
BUN, mg/dL
Creatinine, mg/dL
BUN/creatinine ratio
Calcium, mg/dL
Phosphorus, mg/dL
Chloride, mEq/L
Naive
56 + 6
183 ± 21
143 ± 19
29 + .'
6.8 ± O.1*
5.8 ± 0.1
1.0 ± 0.1
6.4 ± 0.5
146 ± 10
83 ± 3
0.4 ± 0.0
21 ± 1*
1.3 ± 0.0
16 ± 1
10.6 ± 0.2
5.0 ± 0.3
101 ± 1
aAll data expressed as mean ± SEM.
*Significantly different from vehicle control (p S 0.05).
Vehicle
(corn oil)
46 ± 3
207 ± 31
134 ± 11
26 ± 2
7.3 ± 0.2
6.1 ± 0.1
1.2 ± 0.1
5.7 ± 0.6
145 ± 8
80 ± 4
0.5 ± 0.0
18 ± 1
1.2 ± 0.0
15 ± 1
10.9 ± 0.2
4.6 ± 0.2
102 ± 1
DBAN dose
6 mg/kg
35 + 3
169 t 31
130 t 9
-26 t 2
7.5 t 0.2
6.6 t 0.1*
0.9 t 0.2
9.0 t 1.3*
147 t 5
80 t 6
0.5 t 0.0
18 t 1
1.3 t 0.1
14 t 1
11.4 t 0.2
4.8 t 0.1
101 t 1
DBAN dose
23 mg/kg
37 ± 3
174 ± 10
138 ± 19
24 ± 2
7.1 ± 0.2
6.1 ± 0.1
1.1 ± 0.1
6.3 ± 0.8
135 + 10
78 ± 4
0.4 ± 0.1
18 ± 1
1.0 ± 0.1
18 ± 2
11.1 ± 0.2
5.7 ± 0.2*
102 ± 1
DBAN dose
45 mg/kg
32 + 3*
161 ± 11
208 ± 32*
19 ± 1*
6.9 ± 0.2
5.6 ± 0.1*
1.3 ± 0.2
5.3 ± 0.8
130 ± 7
64 ± 3*
0.7 ± 0.0*
15 ± 1
1.0 ± 0.0*
15 ± 1
10.7 ± 0.3
6.2 ± 0.3*
101 ± 1
Organ weights and ratios are summarized in Tables
28 and 29. No remarkable findings were observed at
necropsy, although most organ weights and ratios were
lower in males at 65 mg/kg, and livers appeared to be
larger in treated females. The apparent NOAEL for
DCAN, based on these 90-day data, was determined to
be 8 mg/kg/day.
Discussion
Pereira et al. (20) studied the metabolism and excre-
tion ofhaloacetonitriles (HAN) and reported that 7.7 to
12.8% of orally administered DBAN and DCAN was
converted to thiocyanate and excreted in the urine.
They also reported that some orally administered HAN
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Table 16. Organ weights and ratios at termination of subchronic study of male CD rats exposed to dibromoacetonitrile by gavage.'
Organ
Body weight, g
Brain, mg
% body weight
Liver, mg
% body weight
% brain weight
Spleen, mg
% body weight
% brain weight
Lungs, mg
% body weight
% brain weight
Thymus, mg
% body weight
% brain weight
Kidneys, mg
% body weight
% brain weight
Testes, mg
% body weight
% brain weight
Naive
521.7 ± 12.8
1970 t 60
0.38 ± 0.01
19890 t 670
3.81 ± 0.08
1033 ± 60
810 ± 30
0.16 ± 0.01
42.0 ± 2.2
3060 t 110
0.59 ± 0.02
157.2 ± 6.9
440 ± 20*
0.08 ± 0.00
32.7 ± 1.4*
3770 ± 100
0.73 ± 0.01*
195.6 ± 9.9
3720 ± 60
0.72 ± 0.02*
192.7 ± 8.3
Vehicle
(corn oil)
556.0 ± 12.7
1960 ± 40
0.36 ± 0.01
21850 ± 990
3.93 ± 0.15
1117 ± 50
840 ± 40
0.15 ± 0.01
42.8 ± 1.5
3220 ± 140
0.58 ± 0.03
164.4 ± 7.4
550 ± 30
0.10 ± 0.01
28.4 ± 2.0
3670 ± 100
0.66 ± 0.02
188.2 ± 6.8
3580 ± 50
0.65 ± 0.01
183.3 ± 4.6
DBAN dose
6 mg/kg
545.9 ± 13.5
1980 ± 50
0.37 ± 0.01
21700 ± 680
3.98 ± 0.08
1114 ± 56
840 ± 30
0.15 ± 0.01
42.6 ± 1.8
2950 ± 90
0.54 ± 0.02
150.0 ± 4.9
500 ± 30
0.09 ± 0.01
25.3 ± 1.4
3560 ± 90
0.66 ± 0.02
181.2 ± 5.9
3760 ± 70
0.69 ± 0.02
191.8 ± 6.0
DBAN dose
23 mg/kg
523.1 ± 11.4
1950 ± 40
0.38 ± 0.01
22390 ± 840
4.27 ± 0.12
1157 ± 54
780 ± 40
0.15 ± 0.01
40.1 ± 1.9
3090 ± 110
0.59 ± 0.02
158.3 ± 5.1
530 ± 20
0.10 ± 0.00
27.5 ± 1.3
3620 ± 100
0.69 ± 0.01
186.8 ± 7.0
3490 ± 60
0.67 ± 0.02
180.5 ± 5.7
DBAN dose
45 mg/kg
438.6 7.5*
1930 ± 40
0.44 ± 0.01*
19700 ± 670
4.44 ± 0.13*
1022 ± 32
720 ± 40
0.16 ± 0.01
37.3 ± 2.0
2730 ± 90*
0.63 ± 0.03
141.9 ± 4.5*
430 ± 30*
0.10 ± 0.01
22.6 ± 1.7
3160 ± 100*
0.72 ± 0.02
164.0 ± 4.7*
3510 ± 150
0.80 ± 0.03*
182.8 ± 8.9
aAll data expressed as mean ± SEM.
*Significantly different from vehicle control (p G 0.05).
Table 17. Organ weights and ratios at termination of subchronic study of female CD rats exposed to dibromoacetonitrile by gavage.
Vehicle DBAN dose DBAN dose DBAN dose
Organ Naive (corn oil) 6 mg/kg 23 mg/kg 45 mg/kg
Body weight, g 283.3 ± 7.7 292.9 ± 5.8 279.6 ± 7.3 291.7 ± 9.5 274.9 ± 7.2
Brain, mg 1840 ± 30 1830 ± 30 1810 ± 40 1760 ± 40 1760 ± 40
% body weight 0.66 ± 0.02 0.63 ± 0.02 0.65 ± 0.02 0.61 ± 0.01 0.64 ± 0.02
Liver, mg 11150 ± 420 11620 ± 370 11100 ± 360 12310 ± 330 11950 ± 390
% body weight 3.98 ± 0.17 3.98 ± 0.12 3.98 ± 0.10 4.25 ± 0.11 4.36 ± 0.12
% brain weight 603 ± 18 638 ± 21 619 ± 25 704 ± 21 688 ± 32
Spleen, mg 530 ± 30 510 ± 30 520 ± 20 550 ± 30 570 ± 40
% body weight 0.19 ± 0.01 0.17 ± 0.01 0.19 ± 0.01 0.19 ± 0.01 0.21 ± 0.01
% brain weight 28.9 ± 1.3 27.9 ± 1.8 29.3 ± 1.3 31.2 ± 1.6 32.9 ± 2.4
Lungs, mg 1940 ± 80 2270 ± 150 2340 ± 160 2350 ± 140 2470 ± 170
% body weight 0.69 ± 0.03 0.78 ± 0.05 0.85 ± 0.07 0.81 ± 0.05 0.90 ± 0.06
% brain weight 105.9 ± 4.6 125.1 ± 8.5 129.9 ± 8.4 133.8 ± 6.7 142.3 ± 10.7
Thymus, mg 390 ± 30 400 ± 30 400 ± 30 340 ± 20 260 ± 30*
% body weight 0.14 ± 0.01 0.14 ± 0.01 0.15 ± 0.01 0.12 ± 0.01 1.10 ± 0.01*
% brain weight 21.3 ± 1.6 21.5 ± 1.3 22.7 ± 1.9 19.5 ± 1.2 15.2 ± 1.4*
Kidneys, mg 2080 ± 80 2100 ± 50 1980 ± 60 2010 ± 700 1980 ± 70
% body weight 0.75 ± 0.04 0.72 ± 0.02 0.71 ± 0.02 0.70 ± 0.02 0.72 ± 0.02
% brain weight 112.5 ± 3.0 115.1 ± 3.1 110.2 ± 4.0 115.1 ± 4.0 113.8 ± 4.8
Ovaries, mg 160 ± 10 170 ± 10 170 ± 10 160 ± 10 170 ± 10
% body weight 0.06 ± 0.00 0.06 ± 0.00 0.06 ± 0.00 0.05 ± 0.00 0.06 ± 0.00
% brain weight 8.9 ± 0.4 9.1 ± 0.5 9.2 ± 0.5 8.9 ± 0.5 9.4 ± 0.6
'All data expressed as mean ± SEM.
aSignificantly different from vehicle control at (p S 0.05).
will inhibit hepatic dimethylnitrosamine demethylase
(DMN-DM) activity. Theyconcluded thatHAN are con-
verted to highly toxic metabolites. Daniel et al. (21)
reported that HAN are direct-acting alkylating agents
and could elicit liver and/or other organ toxicity, in-
cludingcarcinogenesis. Thesefindings andthose ofSim-
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Table 18. Serum chemistry mean values for CD male rats exposed to dichloroacetonitrile for 14 days.'
Parameter
SGPT, IU/L
SGOT, IU/L
ALP, IU/L
5'-Nucleotidase, IU/L
Protein, g/dL
Albumin, g/dL
Globulin, g/dL
Alb/globulin ratio
Glucose, mg/dL
Cholesterol, mg/dL
Bilirubin, mg/dL
BUN, mg/dL
Creatinine, mg/dL
BUN/creatinine ratio
Calcium, mg/dL
Phosphorus, mg/dL
Chloride, mEq/L
Vehicle
(corn oil)
70 ± 3
167 ± 13
457 ± 63
14 ± 1
5.8 ± 0.2
4.4 ± 0.1
1.4 ± 0.1
3.1 ± 0.1
154 ± 11
90 ± 5
0.2 ± 0.0
17 ± 2
1.7 ± 0.2
11 ± 3
11.4 ± 0.1
12.3 ± 0.6
100 ± 1
DCAN dose
12 mg/kg
71 ± 6
266 ± 22
459 ± 39
16 ± 1
6.0 ± 0.2
4.3 ± 0.1
1.7 ± 0.1
2.6 ± 0.1*
129 ± 16
93 ± 2
0.2 ± 0.0
17 ± 2
1.4 ± 0.2
12 ± 1
11.0 ± 0.2
12.0 ± 0.8
100± 1
DCAN dose
23 mg/kg
89 ± 22
213 ± 53
384 ± 21
14 ± 2
5.7 ± 0.2
4.3 ± 0.1
1.4 ± 0.2
3.4 ± 0.5
138 ± 6
91 ± 6
0.3 ± 0.0
15 ± 2
1.4 ± 0.1
11 ± 1
11.3 ± 0.2
12.5 ± 0.6
101 ± 1
DCAN dose
45 mg/kg
87± 15
276 ± 40
398 ± 50
17 ± 2
5.5 ± 0.2
4.3 ± 0.1
1.2 ± 0.2
3.8 ± 0.5
134 ± 10
80 ± 10
0.4 ± 0.0*
17 ± 2
1.5 ± 0.1
12 ± 2
9.8 ± 1.5
11.7 ± 0.5
101 ± 2
DCAN dose
90 mg/kg
88 ± 14
233 ± 27
712 ± 84*
23 ± 2*
6.0 ± 0.1
4.8 ± 0.1*
1.2 ± 0.2
4.5 ± 0.7
112 ± 16
81 ± 11
0.6 ± 0.1
15 ± 1
1.4 ± 0.1
11 ± 1
11.7 ± 0.3
12.9 ± 0.4
101 ± 1
aR data expressed as mean ± SEM.
*Significantly different from vehicle control at (p S 0.05).
Table 19. Serum chemistry mean values for CD female rats exposed to dichloroacetonitrile for 14 days.a
Vehicle DCAN dose DCAN dose DCAN dose DCAN dose
Parameter (corn oil) 12 mg/kg 23 mg/kg 45 mg/kg 90 mg/kg
SGPT, IU/L 57 ± 6 66 ± 7 63 ± 4 63 ± 7 134 ± 38*
SGOT, IU/L 205 ± 8 198 ± 6 201 ± 33 181 ± 28 340 ± 96
ALP, IU/L 261 ± 24 381 ± 48 352 ± 45 384 ± 35* 651 ± 159*
5'-Nucleotidase, IU/L 23 ± 3 20 ± 2 16 ± 1 18 ± 1 24 ± 2
Protein, g/dL 6.4 ± 0.3 6.2 ± 0.2 6.4 ± 0.3 5.9 ± 0.2 6.1 ± 0.4
Albumin, g/dL 4.6 ± 0.1 4.4 ± 0.1 4.5 ± 0.1 4.7 ± 0.1 4.8 ± 0.2
Globulin, g/dL 1.8 ± 0.2 1.9 ± 0.2 1.9 ± 0.2 1.2 ± 0.1 1.3 ± 0.3
Alb/globulin ratio 2.8 ± 0.4 2.4 ± 0.2 2.4 ± 0.2 3.9 ± 0.3 4.0 ± 0.7
Glucose, mg/dL 191 ± 19 162 ± 30 142 ± 17 160 ± 6 137 ± 15
Cholesterol, mg/dL 84 3 86 ± 4 99 ± 6 82 ± 8 73 ± 8
Bilirubin, mg/dL 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.4 ± 0.0* 0.7 ± 0.1*
BUN, mg/dL 17 1 17 ± 1 15 ± 2 20 ± 3 23 ± 2
Creatinine, mg/dL 1.6 ± 0.2 1.3 ± 0.1 1.2 ± 0.1 1.6 ± 0.1 1.6 ± 0.2
BUN/creatinine ratio 11 ± 1 13 ± 1 13 ± 2 12 ± 1 14 ± 1
Calcium, mg/dL 11.7 ± 0.5 11.1 ± 0.3 11.3 ± 0.2 11.9 ± 0.3 11.8 ± 0.5
Phosphorus, mg/dL 11.4 ± 0.9 10.9 ± 0.5 11.4 ± 0.9 12.7 ± 0.1 9.9 ± 0.4
Chloride,mEq/L 100 1 99 ± 1 100 ± 1 101 ± 1 101 ± 2
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at (p G 0.05).
and long-term testing, as well as pharmacokinetic and
pharmacodynamic studies, are indicated.
Acute toxicity data for DBAN and DCAN are com-
mon et al. (12), Bull (13), and Meier et al. (14) suggest
that the HAN may be biologically reactive, directly or
by conversion to toxic products. Thorough short-term
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Table 20. Organ weights and ratios of male CD rats exposed to dichloroacetonitrile by gavage for 14 days."
Organ
Body weight, g
Brain, mg
% body weight
Liver, mg
% body weight
% brain weight
Spleen, mg
% body weight
% brain weight
Lungs, mg
% body weight
% brain weight
Thymus, mg
% body weight
% brain weight
Kidneys, mg
% body weight
% brain weight
Testes, mg
% body weight
% brain weight
Vehicle
(corn oil)
157. ± 5
1680 ± 90
1.06 ± 0.03
8150 ± 310
5.19 ± 0.10
494 ± 23
540 ± 40
0.34 ± 0.02
32.6 ± 2.4
1270 ± 70
0.81 ± 0.04
76.9 ± 4.6
430 ± 40
0.27 ± 0.02
25.4 ± 1.7
1530 ± 50
0.98 ± 0.03
93.3 ± 5.1
1540 ± 130
0.97 ± 0.07
91.3 ± 5.4
DCAN dose
12 mg/kg
170 ± 7
1630 ± 120
0.99 ± 0.09
9960 ± 580
5.85 ± 0.16*
687 ± 122
620 ± 70
0.36 ± 0.04
40.9 ± 6.5
1370 ± 110
0.82 ± 0.07
88.1 ± 9.0
550 ± 50
0.32 ± 0.03
37.1 ± 6.4*
1850 ± 80*
1.10 ± 0.04*
125.3 ± 20.0*
1740 ± 150
1.00 ± 0.06
126.8 ± 32.8
DCAN dose
23 mg/kg
147 ± 5
1660 ± 30
1.14 ± 0.04
9710 ± 640
6.57 ± 0.30*
586 ± 39
460 ± 30
0.31 ± 0.01
27.6 ± 1.5
1260 ± 80
0.85 ± 0.05
75.0 ± 4.0
380 ± 20*
0.26 ± 0.02
23.1 ± 1.4
1520 ± 50
1.03 ± 0.02
91.2 ± 2.3
1540 ± 120
1.03 ± 0.06
91.0 ± 6.5
DCAN dose
45 mg/kg
137 + 5
1560 ± 40
1.15 ± 0.04
10110 ± 520*
7.37 ± 0.18*
650 33*
470 ± 50
0.34 ± 0.03
30.2 ± 3.2
1170 ± 70
0.86 ± 0.05
75.0 ± 3.8
330 ± 20*
0.24 ± 0.02
21.3 ± 1.2
1480 ± 60
1.08 ± 0.02
94.6 ± 3.5
1260 ± 130
0.90 ± 0.09
80.3 ± 9.0
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at (p
- 0.05).
Table 21. Organ weights and ratios of female CD rats exposed to dichloroacetonitrile by gavage for 14 days.'
DCAN dose
90 mg/kg
115 + 4
1520 ± 50*
1.34 ± 0.06*
8630 ± 480
7.50 ± 0.26*
576 ± 44
350 ± 30*
0.30 ± 0.02
23.1 ± 1.8*
1020 ± 90
0.89 ± 0.07
67.6 ± 5.6
270 ± 20*
0.24 ± 0.02*
18.2 ± 1.5*
1380 ± 70
1.20 ± 0.04*
91.5 ± 4.3
1250 ± 140
1.07 ± 0.11
80.4 ± 9.3
Organ
Body weight, g
Brain, mg
% body weight
Liver, mg
% body weight
% brain weight
Spleen, mg
% body weight
% brain weight
Lungs, mg
% body weight
% brain weight
Thymus, mg
% body weight
% brain weight
Kidneys, mg
% body weight
% brain weight
Ovaries, mg
% body weight
% brain weight
Vehicle
(corn oil)
148 ±
1610 ±
1.09 ±
8060 ±
5.40 ±
502.9 ±
440 ±
0.30 ±
27.8 ±
1350 ±
0.91 ±
85.0 ±
480 ±
0.33 ±
30.2 ±
1520 ±
1.03 ±
95.2 ±
110 ±
0.08 ±
6.9 ±
6
40
0.04
530
0.20
33.9
30
0.02
2.3
90
0.06
7.4
30
0.02
1.8
50
0.03
3.8
10
0.01
0.0
'All data expressed as mean
± SEM.
*Significantly different from vehicle control (p G 0.05)..
DCAN dose
12 mg/kg
147 ± 6
1520 ± 80
1.04 ± 0.04
8490 ± 350
5.81 ± 0.15
565.7 ± 22.6
430 ± 40
0.30 ± 0.03
29.0 ± 2.7
1170 ± 90
0.80 ± 0.05
77.6 ± 6.1
420 ± 40
0.29 ± 0.03
28.6 ± 3.1
1420 ± 60
0.97 ± 0.03
95.1 ± 4.7
100 ± 10
0.07 ± 0.01
7.0 ± 0.0
DCAN dose
23 mg/kg
143 ± 4
1470 ± 60
1.03 ± 0.03
10560 ± 500*
7.37 ± 0.27*
721.9 ± 31.8*
400 ± 20
0.28 ± 0.02
27.3 ± 1.3
1130 ± 70
0.79 ± 0.05
77.3 ± 4.6
380 ± 30
0.27 ± 0.02
26.0 ± 1.7
1470 ± 40
1.03 ± 0.03
101.7 ± 5.5
100 ± 10
0.07 ± 0.01
6.9 ± 0.0
DCAN dose
45 mg/kg
146 ± 5
1610 ± 50
1.11 ± 0.07
11140 ± 570*
7.59 ± 0.23*
704.8 ± 53.8*
430 ± 20
0.29 ± 0.02
26.8 ± 1.5
1230 ± 100
0.84 ± 0.06
77.1 ± 6.9
420 ± 20
0.29 ± 0.02
26.1 ± 1.6
1510 ± 60
1.03 ± 0.02
95.2 ± 5.7
100 ± 10
0.07 ± 0.01
6.2 ± 0.0
DCAN dose
90 mg/kg
113 ± 5
1450 ± 40
1.30 + 0.06*
7780 ± 920
7.07 ± 0.82*
544.7 ± 67.7
290 ± 20*
0.26 ± 0.01
20.2 ± 1.0*
960 ± 70*
0.86 ± 0.07
65.6 ± 4.2
320 ± 20*
0.29 ± 0.02
22.2 ± 1.8*
1280 ± 50*
1.14 ± 0.04
88.0 ± 2.7
80 ± 10*
0.07 ± 0.01
5.3 ± 0.0
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Table 22. Serum chemistry mean values for CD male rats exposed to dichloroacetonitrile at day 30 and 31 of subchronic study.a
Vehicle
Parameter Naive (corn oil)
SGPT, IU/L 47 ± 7 47 ± 4
SGOT, IU/L 195 ± 32 219 ± 35
ALP, IU/L 268 ± 27 273 ± 26
5'-Nucleotidase, IU/L 13 ± 1 15 ± 1
Protein, g/dL 5.9 ± 0.1* 7.0 ± 0.2
Albumin, g/dL 4.8 ± 0.1 4.7 ± 0.1
Globulin, g/dL 1.1 ± 0.1* 2.3 ± 0.3
Alb/globulin ratio 4.7 ± 0.3 2.3 ± 0.3
Glucose, mg/dL 163 ± 20 141 ± 14
Cholesterol, mg/dL 65 ± 2* 77 ± 5
Bilirubin, mg/dL 0.4 ± 0.0* 0.5 ± 0.0
BUN, mg/dL 19 ± 1 17 ± 1
Creatinine, mg/dL 1.0 ± 0.1 0.9 ± 0.1
BUN/creatinine ratio 19 ± 1 20 ± 2
Calcium, mg/dL 10.5 ± 0.2 11.6 ± 0.4
Phosphorus, mg/dL 8.2 ± 0.2* 9.2 ± 0.4
Chloride, mEq/L 99 ± 1 100 ± 1
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at (p S 0.05).
DCAN dose
8 mg/kg
45 ± 1
187 ± 24
370 ± 34
16 ± 1
6.8 ± 0.2
5.1 ± 0.1*
1.7 ± 0.2
3.6 ± 0.6
147 ± 20
84 ± 3
0.5 ± 0.0
18 ± 0
0.9 ± 0.0
20 ± 1
11.8 ± 0.4
8.6 ± 0.1
101 ± 1
DCAN dose
33 mg/kg
55 ± 4
178 ± 22
453 ± 33*
16 ± 1
6.3 ± 0.2*
4.8 ± 0.1
1.6 ± 0.2*
3.4 ± 0.3
148 ± 1
59 ± 3*
0.5 ± 0.0
17 ± 1
1.2 ± 0.0*
13 ± 1*
11.1 ± 0.4
8.7 ± 0.2
99 ± 1
DCAN dose
65 mg/kg
64 ± 3*
177 ± 13
541 ± 41*
19 ± 1
6.1 ± 0.1*
4.9 ± 0.1
1.2 ± 0.1*
4.6 + 0.4
134 + 6
58 + 2*
0.5 + 0.0
14 + 1*
1.4 ± 0.1*
9 ± 1*
11.3 + 0.2
7.7 + 0.3*
100 ± 1
Table 23. Serum chemistry mean values for CD male rats exposed to dichloroacetonitrile at day 59 and 60 of subchronic study.'
Parameter Naive
SGPT, IU/L 34 + 2 3
SGOT, IU/L 170 ± 19 17'
ALP, IU/L 268 ± 38 29
5'-Nucleotidase, IU/L 17 ± 1 1
Protein, g/dL 6.2 ± 0.1* 7.
Albumin, g/dL 5.3 ± 0.1* 4.
Globulin, g/dL 0.9 ± 0.1* 2.i
Alb/globulin ratio 6.5 ± 0.9* 2.'
Glucose, mg/dL 138 ± 5 13
Cholesterol, mg/dL 60 ± 2* 9
Bilirubin, mg/dL 0.5 ± 0.1 0.
BUN, mg/dL 18 ± 1* 1
Creatinine, mg/dL 1.1 ± 0.0 1.
BUN/creatinine ratio 16 ± 1 11
Calcium, mg/dL 10.1 ± 0.2 10.1
Phosphorus, mg/dL 6.6 ± 0.3 6.1
Chloride, mEg/L 106 ± 1 10
aAll data expressed as mean ± SEM.
*Significantly different from vehicle control at p S 0.05.
Vehicle
corn oil)
4 ± 3
6 ± 16
8 ± 31
8± 2
6 ± 0.3
8 ± 0.1
8 ± 0.4
2 ± 0.5
13± 2
2 ± 11
4 ± 0.0
L5± 1
0 ± 0.0
L6± 1
6 ± 0.4
9 ± 0.4
)4± 1
DCAN dose
8 mg/kg
36 ± 2
176 ± 11
431 ± 40
18 ± 2
6.9 ± 0.2*
5.4 ± 0.1*
1.5 ± 0.2*
4.4 ± 1.1
125 ± 7
89 ± 7
0.4 ± 0.0
15 ± 1
1.2 ±+ 0.1
13 ± 1
10.8 ± 0.2
6.8 ± 0.3
104 ± 1
DCAN dose
33 mg/kg
50 ± 2*
200 ± 12
688 ± 43*
18 ± 1
6.4 ± 0.8
5.2 0.01*
1.2 ± 0.1*
4.6 ± 0.4
133 ± 8
71 ± 5
0.4 ± 0.1
16 ± 1
1.3 0.01*
12 ±+ 1
10.1 ± 0.2
6.8 ± 0.4
106 ± 1
DCAN dose
65 mg/kg
47 + 1*
225 + 40
686 ± 90*
15 ± 1
5.8 ± 0.2*
4.7 ± 0.0
1.1 ± 0.2*
4.9 ± 0.7
162 ± 19
56 ± 5*
0.7 ± 0.1*
12 ± 1
1.2 ± 0.1
10 + 0.0
9.5 + 0.3
6.1 ± 0.2
108 ± 1
pared with data for acetonitrile and acrylonitrile in Ta-
ble 30. The toxicity ofthe DHAN appears to be inter-
mediate between that of acetonitrile and that of
acrylonitrile. The rat and mouse appear to be equally
sensitive to the acute effects of DCAN; however, the
male rat appears to be more sensitive to DBAN than
the female rat.
The data obtained following 14- and 90-day repeated
oraladministration ofDBAN orDCAN toratsrevealed
a dose-dependent decrease in weight gain. Weight gain
is a sensitive indicator of the general health status of
the animal, and the decrease suggests that the body is
responding to the toxic effects of DBAN and DCAN.
The nature of this reaction is not evident, although it
is unlikely that it is caused by chronic cyanide intoxi-
cation. The biochemical data failed to identify specific
targetorgans. Organweightandratiodatasuggestthat
the thymus, liver, spleen, and gonads may be possible
target organs. No consistent, compound-related and
dose-dependent adverse effects were noted except the
effect on body weight. The NOAEL for DBAN was
determinedtobe23mg/kg/day; forDCAN, theNOAEL
was identified as 8 mg/kg/day.
Insight into possible mechanisms oftoxicity and sig-
nificance of the data awaits further studies. For ex-
ample, gavage administration using a corn oil vehicle
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Table 24. Serum chemistry mean values for CD male rats exposed to dichloroacetonitrile at termination of subchronic study."m
Vehicle DCAN dose DCAN dose DCAN dose
Parameter Naive (corn oil) 8 mg/kg 33 mg/kg 65 mg/kg
SGPT,IU/L 38 ±4 53 ±1 45±2 116±60 53± 4
SGOT, IUlL 184 ± 17 195 ± 28 140 ±13 265 ±96 163 ± 18
ALP, IU/L 232 ± 28 222 ± 20 320 ±31 471 ±46* 603 ± 79*
5'Nucleotidase,IU/L 16 ±1 19 ±2 14±1 22±3 21 ± 1
Protein, g/dL 6.8 ± 0.1* 7.5 ± 0.1 7.2 ±0.1 7.0 ±0.1* 6.5 ± 0.1
Albumin, g/dL 5.8 ± 0.1 5.6 ± 0.1 6.0 ±0.1* 5.6 ±0.1* 5.4 ± 0.1
Globulin, g/dL 1.0 ± 0.1 1.9 ± 0.1 1.2 ±0.1 1.4 ±0.1 1.0 ± 0.1
Alb/globulin ratio 6.1 ± 0.4 3.1 ± 0.4 5.3 ±0.4 4.0 ±0.4 5.0 ± 1
Glucose, mg/dL 140 ± 5 145 ± 4 143 ±3 147 ±4 109 ±4*
Cholesterol,mg/dL 68 ± 3 81 ± 6 92 ±6 71 ±5 55 ±4*
Bilirubin, mg/dL 0.4 ± 0.0* 0.5 ± 0.0 0.5 ±0.0 0.5 ±0.1 0.6 ±0.1
BUN,mg/dL 20± 0.6* 14 ±1 13±1 14±1 16±2
Creatinine, mg/dL 1.1 ± 0.1 1.1 ± 0.0 1.1 ±0.0 1.2 ±0.0 1.2 ±0.0
BUN/creatinine ratio 17.9 ± 1 13.8 ± 1 11.7 ± 0.7 11.4 ±0.7 13.2 ±1
Calcium, mg/dL 9.3 ± 0.1* 10.1 ± 0.2 9.4 ± 0.1* 9.6 ±0.2 9.2 ±0.3*
Phosphorus, mg/dL 5.5 ± 0.2 5.7 ± 0.3 5.1 ± 0.2 6.1 ± 0.4 5.9 ± 0.3
Chloride,mEq/L 105 ±1 105± 1 103 ±1 103 ±1 107± 1
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at p 0.05.
Table 25. Serum chemistry values for CD female rats exposed to dichloroacetonitrile at day 30 and 31 of subchronic study.'m
Vehicle DCAN dose DCAN dose DCAN dose
Parameter Naive (corn oil) 8 mg/kg 33 mg/kg 65 mg/kg
SGPT,IU/L 43 ±4 38 ±3 39 ±8 42 ±3 44± 2
SGOT, IUlL 178 ± 23 171 ± 12 175 ± 11 138 ± 12 161 ± 22
ALP, IU/L 205 ± 16 223 ± 16 202 ± 21 210 ± 12 269 ± 17
5'-Nucleotidase, IU/L 30 ± 3 34 ± 3 24 ± 2* 18 ± 1* 21 ± 1*
Protein, g/dL 6.3 ± 0.1 6.6 ± 0.1 6.8 ± 0.1 6.7 ± 0.2 6.0 ± 0.2*
Albumin, g/dL 5.2 ± 0.1 5.6 ± 0.1 5.3 ± 0.1 5.4 ± 0.1 4.9 ± 0.2*
Globulin, g/dL 1.1 ± 0.1 1.0 ± 0.1 1.6 ± 0.1* 1.2 ± 0.1 1.1 ±0.2
Alb/globuHin ratio 5.3 ± 0.6 6.2 ± 0.8 3.5 ± 0.2* 4.7 ± 0.4 5.3 ± 0.7
Glucose,mg/dL 147 ±6 145± 3 138 ±4 127 ±6 143± 8
Cholesterol,mg/dL 80 ± 4 86 ± 3 73 ± 5 76 ± 4 56 ± 3*
Bilirubin, mg/dL 0.4 ± 0.0* 0.6 ± 0.0 0.5 ± 0.0* 0.5 ± 0.0* 0.4 ± 0.0*
BUN,mg/dL 19 ±1 17 ±1 18 ±1 21 ±1 20± 1
Creatinine, mg/dL 1.0 ± 0.0 0.9 ± 0.0 0.9 ± 0.1 1.3 ± 0.0 1.4 ± 0.1*
BUN/creatinine ratio 19 ± 1 18 ± 1 20 ± 2 16 ± 1 14 ± 1*
Calcium, mg/dL 10.6 ± 0.2 10.8 ± 0.3 10.8 ± 0.3 11.2 ± 0.3 10.5 ± 0.2
Phosphorus, mg/dL 7.9 ± 0.2* 6.8 ± 0.3 7.4 ± 0.3 6.9 ± 0.3 7.0 ± 0.2
Chloride,mEg/L 100 ±2 101± 1 97 ±1 99 ±2 99 ±1
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at p 0.05.
Table 26. Serum chemistry mean values for CD female rats exposed to dichloroacetonitrile at day 59 and 60 of subchronic study.'m
Vehicle DCAN dose DCAN dose DCAN dose
Parameter Naive (corn oil) 8 mg/kg 33 mg/kg 65 mg/kg
SGPT,IU/L 36 ±5 33 ±2 40 ±5 51 ±12 35 ±4
SGOT,IU/L 143 ±10 143± 12 163 ±24 198 ±36 225 ±97
ALP, IU/L 188 ± 20 207 ± 21 260 ± 28 295 ± 21 557 ± 79*
5'-Nucleotidase, IU/L 28 ± 3 32 ± 2 19 ± 2* 18 ± 2* 16 ± 3*
Protein, g/dL 6.6 ± 0.1* 7.2 ± 0.2 6.9 ± 0.1 6.8 ± 0.1 6.0 ± 0.2*
Albumin, g/dL 5.7 ± 0.1 5.6 ± 0.1 6.0 ± 0.1* 5.9 ± 0.1 5.3 ± 0.1
Globulin, g/dL 0.9 ± 0.1* 1.5 ± 0.2 0.9 ± 0.1* 0.8 ± 0.1* 0.6 ±0.2*
Alb/globulin ratio 7.3 ± 0.1 4.3 ± 0.6 7.4 ± 0.8 8.0 ± 1.0* 9.4 ±2.0*
Glucose, mg/dL 144 ± 4 137 ± 3 140 ± 6 143 ± 13 176 ±16*
Cholesterol,mg/dL 81 ±4 78 ± 4 83 ± 6 73 ± 3 50 ±1*
Bilirubin, mg/dL 0.4 ±0.0 0.5 ± 0.0 0.4 ± 0.1 0.3 ± 0.0* 0.6 ±0.0
BUN,mg/dL 20±0* 16 ±0 17 ±1 19 ±1* 13±1
Creatinine, mg/dL 1.2 ±0.1 1.2 ± 0.1 1.2 ± 0.1 1.4 ± 0.1 1.4 ±0.2
BUN/creatinineratio 17±1 14 ±1 15 ±1 14 ±1 10 ±1
Calcium, mg/dL 10.3 ±0.1 10.5 ± 0.3 10.3 ± 0.1 10.6 ± 0.1 10.2 ± 0.3
Phosphorus, mg/dL 5.7 ± 0.1 5.4 ± 0.3 5.1 ± 0.2 5.1 ± 0.3 4.4 ± 0.5
Chloride,mEq/L 105 ± 1 107 ± 1 106 ± 1 105 ± 1 107 ± 3
"All data expressed as mean ± SEM.
*Significantly different from vehicle control at p 0.05.
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Table 27. Serum chemistry mean values for CD female rats exposed to dichloroacetonitrile at termination of subchronic study.8
Vehicle
Parameter Naive (corn oil)
SGPT, IU/L 51 ± 7 51 ± 3
SGOT, IU/L 198 ± 29* 120 ± 14
ALP, IU/L 146 ± 20 228 ± 29
5-Nucleotidase, IU/L 28 ± 2 30 ± 2
Protein, g/dL 6.9 ± 0.1 7.1 ± 0.1
Albumin, g/dL 6.1 ± 0.1 6.2 ± 0.2
Globulin, g/dL 0.8 ± 0.1 0.9 ± 0.1
Alb/globulin ratio 8.4 ± 0.7 7.0 ± 1
Glucose, mg/dL 144 ± 8 150 ± 6
Cholesterol, mg/dL 92 ± 5* 73 ± 3
Bilirubin, mg/dL 0.4 ± 0.0 0.5 ± 0.0
BUN, mg/dL 19 ± 1* 15 ± 1
Creatinine, mg/dL 1.2 ± 0.1 1.1 ± 0.0
BUN/creatinine ratio 16 ± 1 14 ± 1
Calcium, mg/dL 9.6 ± 0.1 9.7 ± 0.1
Phosphorus, mg/dL 5.4 ± 0.2 5.0 ± 0.2
Chloride, mEq/L 105 ± 1 107 ± 1
aAll data expressed as mean ± SEM.
*Significantly different from vehicle control at p S 0.05.
DCAN dose
8 mg/kg
32 + 2*
127 ± 15
226 ± 25
19 ± 1*
7.3 ± 0.1
6.0 ± 0.1
1.3 ± 0.1
5.1 ± 0.4
127 ± 5*
96 ± 6*
0.4 ± 0.0
16 ± 1
1.2 ± 0.1
13 ± 1
10.1 ± 0.2
5.1 ± 0.2
106 ± 2
DCAN dose
33 mg/kg
27 ± 2*
124 ± 14
286 ± 30
16 ± 1*
7.1 ± 0.1
6.0 ± 0.1
1.1 ± 0.1
6.0 ± 0.4
140 ± 5
80 ± 7
0.4 ± 0.0
15 ± 1
1.2 ± 0.1
12 ± 1
9.8 ± 0.2
5.4 ± 0.2
105 ± 1
DCAN dose
65 mg/kg
35 ± 3*
126 ± 16
499 ± 46*
17 ± 1*
6.6 ± 0.1*
5.5 ± 0.1*
1.1 ± 0.1
5.0 ± 1
120 ± 6*
54 ± 4*
0.5 ± 0.0
16 ± 1
1.4 ± 0.1*
12 ± 1
9.8 ± 0.2
5.0 ± 0.2
106 ± 1
Table 28. Organ weights and ratios of male CD rats exposed to dichloroacetonitrile by gavage for 90 days.a
Parameter
Body weight, g
Brain, mg
% body weight
Liver, mg
% body weight
% brain weight
Spleen, mg
% body weight
% brain weight
Lungs, mg
% body weight
% brain weight
Thymus, mg
% body weight
% brain weight
Kidneys, mg
% body weight
% brain weight
Testes, mg
% body weight
% brain weight
Naive
532.5 ± 11.1
1820 ± 60
0.34 ± 0.01
19300 ± 750
3.6 ± 0.50
1080 ± 51
780 ± 40
0.15 ± 0.03
44 ± 3.0
2700 ± 120
0.51 ± 0.02
150.0 ± 6.0
580 ± 30
0.11 ± 0.01
33.0 ± 2.0
3840 ± 80
0.73 ± 0.02
210.0 ± 8.0
3490 ± 80
0.66 ± 0.02
200.0 ± 8.0
Vehicle
(corn oil)
541.4 ± 13.1
1860 ± 60
0.35 ± 0.01
21430 ± 730
4.0 ± 0.10
1170 ± 47
720 ± 30
0.13 ± 0.03
40 ± 2.0
2980 ± 130
0.56 ± 0.02
160.0 ± 8.0
600 ± 30
0.12 ± 0.01
33.0 ± 2.0
3710 ± 70
0.69 ± 0.01
200.0 ± 8.0
3420 ± 80
0.63 ± 0.02
190.0 ± 8.0
DCAN dose
8 mg/kg
572.1 ± 14.5
1840 ± 70
0.33 ± 0.02
25830 ± 1040
4.5 ± 0.13
1430 ± 86*
730 ± 30
0.13 ± 0.02
41 ± 3.0
2770 ± 130
0.49 ± 0.02*
150.0 ± 10.0
790 ± 40*
0.14 ± 0.01
44.0 ± 3.0*
3880 ± 120
0.68 ± 0.02
220.0 ± 13.0
3660 ± 60
0.65 ± 0.02
200.0 ± 10.0
DCAN dose
33 mg/kg
438.0 ± 16.6*
1860 ± 60
0.44 ± 0.02*
27260 ± 1060
6.4 ± 0.43*
1500 ± 62*
630 ± 30
0.15 ± 0.04
35 ± 2.0
2630 ± 100
0.61 ± 0.02
140.0 ± 6.0
620 ± 30
0.15 ± 0.01*
34.0 ± 2.0
3450 ± 120
0.81 ± 0.04*
190.0 ± 8.0
3400 ± 70
0.80 ± 0.04*
190.0 ± 6.0
DCAN dose
65 mg/kg
285.6 ± 20.6*
1770 ± 60
0.63 ± 0.03*
17910 ± 1600
6.4 ± 0.92*
1022.5 ± 128
500 ± 60*
0.18 ± 0.03*
29.0 ± 4.0
1830 ± 60*
0.65 ± 0.04
103.0 ± 1.0*
310 ± 30*
0.11 ± 0.02
18.0 ± 3.0*
2770 ± 190*
1.0 ± 0.12*
160.0 ± 15.0
2910 ± 150*
1.0 ± 0.12*
170.0 ± 14.0
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at p : 0.05.
doesnotsimulatehumanexposureconditions. Thisissue
iscurrentlybeingaddressedbythe NationalToxicology
Program. Limited water solubility and lack of accep-
tance by rats in taste aversion studies necessitates the
use of a solvent to assess effects at high doses. Limit
studies (solubility limit in water) should be considered.
The histopathological evaluation of major organs (tis-
sues) from exposed animals should provide some infor-
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Table 29. Organ weights and ratios of female CD rats exposed to dichloroacetonitrile by gavage for 90 days.
Vehicle
Parameter Naive (corn
Body weight, g 290.0 ± 7.3 309.0 ±
Brain, mg 1790 ± 40 1680 ±
% body weight 0.63 ± 0.02 0.55 ±
Liver, mg 11000 ± 540 12100 ±
% body weight 3.8 ± 0.11 4.0 ±
% brain weight 615.0 ± 27.8 737.2 ±
Spleen, mg 650 ± 120 540 ±
% body weight 0.22 ± 0.04 0.18 ±
% brain weight 36.6 ± 6.5 33.1 ±
Lungs, mg 1970 ± 90 2040 ±
% body weight 0.68 ± 0.03 0.67 ±
% brain weight 109.8 ± 3.7 1226 ±
Thymus, mg 430 ± 10 500 ±
% body weight 0.15 ± 0.004 0.16 ±
% brain weight 24.3 ± 1.0 30.6 ±
Kidneys, mg 2230 ± 70 2230 ±
% body weight 0.77 ± 0.02 0.72 ±
% brain weight 125.2 ± 3.8 136.7 ±
Ovaries, mg 140 ± 10 160 ±
% body weight 0.05 ± 0.003 0.05 ±
% brain weight 8.2 ± 0.6 9.9 ±
'All data expressed as mean ± SEM.
*Significantly different from vehicle control at p S 0.05.
oil)
6.91
70
0.02
420
0.14
37.5
20
0.01
1.9
100
0.03
6.9
30
0.01
1.8
60
0.01
6.9
10
0.004
1.0
DCAN dose
8 mg/kg
282.5 ± 17.4
1690 ± 70
0.57 ± 0.02
14130 ± 870
4.7 ± 0.29*
1430 ± 86*
560 ± 30
0.19 ± 0.01
34.4 ± 2.6
2200 ± 150
0.74 ± 0.05
134.7 ± 13.0
540 ± 30
0.18 ± 0.01
33.0 ± 2.4
2380 ± 60
0.80 ± 0.02
145.4 ± 8.4
140 ± 10
0.05 ± 0.002
8.1 + 0.4
DCAN dose
33 mg/kg
280.6 ± 10.7
1580 + 60
0.58 ± 0.03
16830 ± 580*
6.1 ± 0.22*
1092.5 55.9*
500 ± 20
0.18 ± 0.01
32.6 ± 2.2
2220 ± 160
0.79 ± 0.03*
148.3 ± 16.5
420 ± 20*
0.15 ± 0.01
27.5 ± 2.3
2200 ± 80
0.80 ± 0.03
143.5 ± 7.7
140 ± 10
0.05 ± 0.003
9.5 ± 0.7
DCAN dose
65 mg/kg
225.5 ± 8.9*
1460 80
0.66 ± 0.05
13880 705
6.1 ± 0.15*
993.5 ± 98.4*
450 ± 20
0.20 ± 0.01
31.9 ± 2.6
1830 ± 100
0.82 _ 0.05*
130.4 12.8
375 ± 20*
0.17 0.01
26.5 ± 1.9
2250 120
1.00 ± 0.02*
163.6 17.3
100 ± 20*
0.05 ± 0.01
7.1 _ 1.4
Table 30. A comparison of acute toxicity data of a series of nitriles.
Study Acrylonitrile Acetonitrile Dibromoacetonitrile Dichloroacetonitrile
Oral LD,,, mg/kg
Rat
M 93 3,800 245 (210-286) 389 (298-387)
F 361 (320-410) 330 (300-500)
Mouse
M 27 289 (253-324) 270 (241-303)
F 303 (269-342) 279 (263-296)
Inhalation LC5i
Rat
M 7,551 ppm/8H
F 12,435 ppm/8H
Dermal LD50
Rabbit 0.25 ml/kg 1,250 mg/kg
Mutagenicity
S. typhimurium Positive Negative (?) Positive
mation on effects at the cellular level. The pharmaco-
kinetic and pharmacodynamic studies on HAN in corn
oil, in water, or in other solvents, administered by gav-
age and in drinking water, should be considered.
Estimates of human exposure to HAN in drinking
water and from other sources including occupational
exposure are lacking. Lifetime toxicity/oncogenicity
studies are indicated since the HAN are reported to be
mutagenic and probablycarcinogenic. Thedefinitive an-
swerresidesinchronictoxicitystudiesinintactanimals.
These studies were supported by Cooperative Agreement No.
808861 from the Environmental Protection Agency.
This paper has been reviewed in accordance with the U.S. Envi-
ronmental Protection Agency's peer and administrative review poli-
cies and has been approved for publication as an EPA document.
Mention of trade names or commercial products does not constitute
endorsement or recommendation for use.
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